Logistic analysis results supported the role of plasma levels of IGF2, LYVE1, PPBP, and THBS1 as potential biomarkers that indicate a significantly increased risk of AIS due to LVO (Table 3). Here, IGF2 is linked to androgen insensitivity syndrome.